Recall Record

Piscataway, NJ, United States

Camber Pharmaceuticals Inc recalls

3 recalls recorded since 2018, most recently on 13 March 2023. 2 are listed as ongoing. Status and classification are as published by the FDA.

Recalls3
Ongoing (FDA)2
Terminated or completed1
Class I (FDA)1

Ongoing Class I Drugs

Recall started
13 March 2023
Reason
Microbial Contamination of Non-Sterile Product: Objectionable organism, identified as Bacillus cereus, found in product during testing of repackaged product.
Distribution
Nationwide in the USA
Initiated
Voluntary: Firm initiated
Recall number
D-0567-2023

Terminated Class III Drugs

Recall started
6 December 2022
Terminated
15 March 2024
Reason
Failed Excipient Specifications: out of specification result observed for p-Hydroxybenzoic Acid content
Distribution
USA Nationwide
Initiated
Voluntary: Firm initiated
Recall number
D-0094-2023

Ongoing Class II Drugs

Recall started
28 February 2019
Reason
CGMP Deviations; trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) detected in the active pharmaceutical ingredient
Distribution
Nationwide
Initiated
Voluntary: Firm initiated
Recall numbers
D-1042-2019, D-1043-2019, D-1041-2019

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.